Effect of a Community Pharmacist–Delivered Diabetes Support Program for Patients Receiving Specialty Medical Care: A Randomized Controlled Trial

The Diabetes Educator

Volumn 41, Issue 1, 2015, Pages 127-135

  Jahangard Rafsanjani, Zahra ^a   Sarayani, Amir ^b   Nosrati, Marzieh ^c   Saadat, Navid ^d   Rashidian, Arash ^c   Hadjibabaie, Molouk ^b   Ashouri, Asieh ^b   Radfar, Mania ^a   Javadi, Mohammadreza ^b   Gholami, Kheirollah ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; BLOOD; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; IRAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PHARMACIST; PHARMACY; PROCEDURES; PROGRAM EVALUATION; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SELF CARE;

AGED; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IRAN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACIES; PHARMACISTS; PROGRAM EVALUATION; SELF CARE;

EID: 84921632897     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721714559132     Document Type: Article

References (30)

1. Danaei G, Finucane MM, Lu Y et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 27 million participants. Lancet. 2011;378(9785):31-40.
2. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311-321.
3. Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43(5):882-889.
4. Norris SL, Engelgau MM, Venkat Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24(3):561-587.
5. Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12(1):57.
6. Coyle ME, Francis K, Chapman Y. Self-management activities in diabetes care: a systematic review. Aust Health Rev. 2013;37(4):513-522.
7. Association AD. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
8. Nkansah N, Mostovetsky O, Yu C et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;7(7).
9. Krass I, Mitchell B, Clarke P et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract. 2007;75(3):339-347.
10. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-436.
11. Sisson E, Kuhn C. Pharmacist roles in the management of patients with type 2 diabetes. J Am Pharm Assoc. 2009;49(suppl 1):S41-S45.
12. Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract. 2011;92(2):145-152.
13. Krass I, Mitchell B, Clarke P et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract. 2007;75(3):339-347.
14. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49(3):383-391.
15. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569-1582.
16. Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low-and middle-income countries. Cochrane Database Syst Rev. 2013;2.
17. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216-221.
18. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943-950.
19. De Berardis G, Pellegrini F, Franciosi M et al. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care. 2004;27(2):398-406.
20. Tricco AC, Ivers NM, Grimshaw JM et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833): 2252-2261.
21. Sarkadi A, Rosenqvist U. Experience-based group education in type 2 diabetes: a randomised controlled trial. Patient Educ Couns. 2004;53(3):291-298.
22. Clifford RM, Davis WA, Batty KT, Davis TME. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28(4):771-776.
23. Stratton IM, Adler AI, Neil HAW et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-412.
24. Sarayani A, Rashidian A, Gholami K, Torkamandi H, Javadi M. Efficacy of continuing education in improving pharmacists’ competencies for providing weight management service: three-arm randomized controlled trial. J Contin Educ Health Prof. 2012;32(3):163-173.
25. O'Neal K, Crosby K. What is the role of the pharmacist in obesity management? Current Obesity Reports. 2014:1-9.
26. Mitchell B, Armour C, Lee M et al. Diabetes medication assistance service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Educ Couns. 2011;83(3):288-294.
27. Krass I, Delaney C, Glaubitz S, Kanjanarach T. Measuring patient satisfaction with diabetes disease state management services in community pharmacy. Res Social Adm Pharm. 2009;5(1):31-39.
28. Welschen LMC, Bloemendal E, Nijpels G et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28(6):1510-1517.
29. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271-278.
30. Hosseininasab M, Jahangard-Rafsanjani Z, Mohagheghi A et al. Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial. Am J Hypertens. 2014;11:1339-1345.